The European Medicines Agency's strategies to meet the challenges of Alzheimer disease
- PMID: 25829266
- DOI: 10.1038/nrd4585
The European Medicines Agency's strategies to meet the challenges of Alzheimer disease
Abstract
Regulatory agencies have a key role in facilitating the development of new drugs for Alzheimer disease, particularly given the challenges associated with early intervention. Here, we highlight the strategies of the European Medicines Agency to help address such challenges.
References
-
- Eur Neuropsychopharmacol. 2011 Nov;21(11):781-8 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
